Showing results (1021-1030 of 1,159) with videos related to

Sort By:
Pageof 116
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 21, 2007
The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signalingJoseph Tam, Victoria Trembovler, Vincenzo Di Marzo, et al.
Cell Death & Disease|September 15, 2020
P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesotheliomaCaterina Costa, Paola Indovina, Eliseo Mattioli, et al.
International Journal of Obesity (2005)|May 4, 2023
Hypoabsorptive surgeries cause limb-dependent changes in the gut endocannabinoidome and microbiome in association with beneficial metabolic effectsPaulette Mukorako, David H St-Pierre, Nicolas Flamand, et al.
Pharmacological Reviews|November 17, 2010
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂R G Pertwee, A C Howlett, M E Abood, et al.
La Clinica Terapeutica|February 11, 2022
Intradermal therapy (mesotherapy): the lower the betterB Bifarini, F Gori, D Russo, et al.
Bioorganic & Medicinal Chemistry|July 15, 2009
Synthesis, cannabinoid receptor affinity, molecular modeling studies and in vivo pharmacological evaluation of new substituted 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides. 2. Effect of the 3-carboxamide substituent on the affinity and selectivity profileRomano Silvestri, Alessia Ligresti, Giuseppe La Regina, et al.
British Journal of Pharmacology|November 15, 2005
New potent and selective inhibitors of anandamide reuptake with antispastic activity in a mouse model of multiple sclerosisAlessia Ligresti, Maria Grazia Cascio, Gareth Pryce, et al.
Eating and Weight Disorders : EWD|March 10, 2001
Anxiety, depression, hunger and body composition: III. Their relationships in obese patientsP Cugini, M Cilli, A Salandri, et al.
ACS Chemical Neuroscience|February 5, 2020
Protective Effects of N-Oleoylglycine in a Mouse Model of Mild Traumatic Brain InjuryFabiana Piscitelli, Francesca Guida, Livio Luongo, et al.
European Journal of Medicinal Chemistry|February 13, 2014
1,2-Dihydro-2-oxopyridine-3-carboxamides: the C-5 substituent is responsible for functionality switch at CB2 cannabinoid receptorValentina Lucchesi, Teija Parkkari, Juha R Savinainen, et al.
Pageof 116